Phage Based Diagnostics

01359 231856

Twitter Youtube Linkedin Envelope
  • Home
  • About
    • About PBD Biotech
    • Industry Awards
    • Management Team
    • International
  • Actiphage
    • About Actiphage
    • Benefits of Actiphage
    • Rapid detection of mycobacterial disease
  • Bovine
    • Bovine TB
    • Johne’s Disease
  • Latest
    • Articles
    • Events
  • Case Studies
  • Research
  • Contact
    • Product Order Form
    • Contacting us
Menu
  • Home
  • About
    • About PBD Biotech
    • Industry Awards
    • Management Team
    • International
  • Actiphage
    • About Actiphage
    • Benefits of Actiphage
    • Rapid detection of mycobacterial disease
  • Bovine
    • Bovine TB
    • Johne’s Disease
  • Latest
    • Articles
    • Events
  • Case Studies
  • Research
  • Contact
    • Product Order Form
    • Contacting us
Search
Generic filters

Novel TB diagnostics paper to be presented at ECCMID 2022

Date: 23-26 April 2022

Jee-Whang Kim of Leicester Tuberculosis Research Group (LTBRG) is to present a paper in the ‘hot topics in tuberculosis’ session at ECCMID 2022
ECCMID conference

The 32nd European Congress of Clinical Microbiology & Infectious Diseases (ECCMID 2022), taking place in Lisbon, Portugal from April 23-26 will be a hybrid event for the first time, so hopefully even more people will be able to attend this prestigious conference.

We are delighted that Jee-Whang Kim of the Leicester Tuberculosis Research Group (LTBRG) will be presenting a paper in the ‘Hot topics in tuberculosis’ session at 13:30 -14:30 on Tuesday 26th April.

The paper is called: “A novel bacteriophage-based assay stratifies tuberculosis risk in recent household contacts of pulmonary tuberculosis: a prospective observational cohort study’

The paper builds on a pilot study by Dr Pranab Haldar, Clinical Senior Lecturer (University of Leicester) and Dr Ben Swift, Director of Research and Development at PBD Biotech with others, that showed the potential of Actiphage as diagnostic for patients with active and incipient TB.

LTBRG is a group of scientists and academic clinicians focused on the discovery, development and implementation of knowledge to overcome the health, economic and social impact of tuberculosis (TB) at a local, national and global level.

https://www.eccmid.org/

Share:
  • Actiphage, Events

Related posts

Loading...
bison MAP diagnostic

Actiphage identifies strain of mycobacteria in blood of bison

May 26, 2022
Results presented at ICP (12-16th June) from first study in North American bison, shows capacity of Actiphage to sub-type mycobacteria in blood.
bison MAP diagnostic

Actiphage identifies strain of mycobacteria in blood of bison

May 26, 2022
Results presented at ICP (12-16th June) from first study in North American bison, shows capacity of Actiphage to sub-type mycobacteria...
ICP 2022

12 -16th June 2022

ICP 2022

May 26, 2022
The role of Actiphage® as a powerful research tool for tuberculosis-related diseases is to be explored at the 15th International Association for Paratuberculosis Colloquium (ICP2022) in Dublin on 12 – 16th June 2022.
ICP 2022

12 -16th June 2022

ICP 2022

May 26, 2022
The role of Actiphage® as a powerful research tool for tuberculosis-related diseases is to be explored at the 15th International...
Cath Rees

21-23 August 2022

The Science of Artisan Cheese

May 25, 2022
Prof. Cath Rees CSO has spoken at the conference on several occasions and is delighted to be invited back to talk about developments in Actiphage, and its application to test milk for the presence of bTB and MAP.
Cath Rees

21-23 August 2022

The Science of Artisan Cheese

May 25, 2022
Prof. Cath Rees CSO has spoken at the conference on several occasions and is delighted to be invited back to...
ECCMID

Actiphage® TB diagnostic finds live mycobacterium tuberculosis in the blood of people with incipient TB

April 23, 2022
A clinical trial of Actiphage, a promising new diagnostic for tuberculosis infection, has shown for the first time that live bacteria can be detected in the blood of people with incipient TB infection.
ECCMID

Actiphage® TB diagnostic finds live mycobacterium tuberculosis in the blood of people with incipient TB

April 23, 2022
A clinical trial of Actiphage, a promising new diagnostic for tuberculosis infection, has shown for the first time that live...
1 2 … 5 Next »

developers of phage-based diagnostics

Contact Us

PBD Biotech Ltd
Link House, Elm Farm Park,
Great Green, Thurston,
Suffolk IP31 3SH,
United Kingdom

Registered Company Address
Ingenuity Centre,
University of Nottingham,
Innovation Park, Triumph Rd,
Nottingham NG7 2TU,
United Kingdom

T: 01359 231856
info@pbdbio.com

Privacy and cookies policy

© 2022 PBD Biotech Ltd

design: out of house

  • Follow Us!
PBD Biotech

If you are going @CheshireShow there is an opportunity to talk to @ZaraBewizibet senior scientific adviser to Defra TB Policy. She is on the Cheshire Badger Vaccination Project @CBVP2021 stand. Good to see some joined up thinking #BadgerTrust #EndTB

Read More
PBD Biotech

@PeterMullowney Thank you @PeterMullowney for a very productive conference with many inspiring presentations. So good to see everyone @paratb2022

Read More
PBD Biotech

@1GarethWynJones @downtoearthuk_ @clovermad Mum always knows best 😉 Well done @clovermad for hosting.

Read More